01st week of 2016 patent applcation highlights part 22 |
Patent application number | Title | Published |
20160002108 | Targeted Air Control for Carbon Containing Fly Ash - Compositions and methods of the present invention comprise the use of at least one alkoxylated fatty compound comprising at least one propylene oxide group, the alkoxylated fatty compound having a turbidity most preferably greater than 1000 NTU (as measured in a 0.2 weight percent aqueous solution) and carbon dispersing compound (e.g., lignosulfonate) to reduce carbon spotting in mortars and concretes containing a carbon-bearing fly ash having a methylene blue (MB) value of at least 1 mg/g or greater (as 10 determined according to ASTM C1777-13). The compositions may, for example, be combined as dry powder with the carbon-bearing fly ash where the fly ash is produced, or in aqueous liquid composition form, such as would be suitable for dispensing at a concrete ready-mix plant. Exemplary additive or admixture compositions may further comprise air entraining agents, alkanolamines, or both. | 2016-01-07 |
20160002109 | PROCESS FOR THE MANUFACTURING OF SLABS OR BLOCKS OF CONGLOMERATE OF STONE GRANULATE AND POLYESTER RESIN - In the manufacture of articles in slabs or blocks according to so-called Bretonstone technology, a polyester resin is employed, free of reactive solvents, formed by the reaction between an epoxidised triglyceride and at least one carboxylic anhydride. | 2016-01-07 |
20160002110 | JOINED BODY AND METHOD FOR PRODUCING THE SAME - A joined body | 2016-01-07 |
20160002111 | DIELECTRIC CERAMIC COMPOSITION AND MULTILAYER CERAMIC CAPACITOR INCLUDING THE SAME - A dielectric ceramic composition may include a base material main ingredient and an accessory ingredient. The accessory ingredient contains one or more selected from a group consisting of oxides and carbonates of one or more elements among Bi, Li, and Cu. When the accessory ingredient contains Bi, a content of Bi may be 0.1 to 1.0 part by mole, based on 100 parts by mole of the base material main ingredient, when the accessory ingredient contains Li, a content of Li may be 0.1 to 1.0 part by mole, based on 100 parts by mole of the base material main ingredient, and when the accessory ingredient contains Cu, a content of Cu may be 0.1 to 1.0 part by mole, based on 100 parts by mole of the base material main ingredient. | 2016-01-07 |
20160002112 | BODY MADE OF A CERAMIC MATERIAL - A body made of a ceramic material stabilized by a stabilizing agent and a process for preparing the body. The body includes a surface region extending from the surface of the body to a predetermined depth. The stabilizing agent is enriched in the surface region. The proportion of the stabilizing agent in the surface region continuously increases from the predetermined depth to the surface. The process includes applying the stabilizing agent to the surface of a basic body made of a ceramic material and heating the basic body with the stabilizing agent applied thereon at a temperature such that at least a portion of the stabilizing agent diffuses into the ceramic material. | 2016-01-07 |
20160002113 | DIELECTRIC CERAMIC COMPOSITION AND COMPOSITE CERAMIC STRUCTURE - Barium titanate (BaTiO | 2016-01-07 |
20160002114 | DIELECTRIC CERAMIC COMPOSITION AND COMPOSITE CERAMIC STRUCTURE - Strontium titanate (SrTiO | 2016-01-07 |
20160002115 | Synthesis and Processing of Ultra High Hardness Boron Carbide - A super-hard material is a late transition metal doped B | 2016-01-07 |
20160002116 | FLUORIDE SINTERED BODY FOR NEUTRON MODERATOR AND METHOD FOR PRODUCING THE SAME - A fluoride sintered body suitable for a moderator which moderates high-energy neutrons so as to generate neutrons for medical care with which an affected part of the deep part of the body is irradiated to make a tumor extinct comprises MgF | 2016-01-07 |
20160002117 | TRANSPARENT SPINEL ARTICLE AND TAPE CAST METHODS FOR MAKING - A transparent, tape casted, spinel article, as defined herein. Also disclosed is a method of method of making the tape casted, transparent spinel, and laminates of the tape casted. transparent spinel, as defined herein. | 2016-01-07 |
20160002118 | POLYPHOSPHATE FERTILIZER COMBINATIONS - A composite particle and a population of particles comprising a water-insoluble polyphosphate composition, methods of producing, and methods of using the same are provided. The polyphosphate composition may comprise at least one alkaline earth metal selected from calcium and magnesium and optionally at least one nutrient ion selected from the group consisting of potassium, ammonium, zinc, iron, manganese, copper, boron, chlorine, iodine, molybdenum, selenium or sulfur. | 2016-01-07 |
20160002119 | BIOREMEDIATION OF SURFACE WATER OIL SPILLS - A process for bioremediating a surface water oil spill includes mixing organic fertilizer with a floatable material selected from saw dust, wood shavings, and a combination thereof to produce a floatable bacterial nutrient, and applying the floatable bacterial nutrient onto an oil spill-impacted water surface. Hydrocarbon-digesting microbes can be added to the floatable bacterial nutrient. | 2016-01-07 |
20160002120 | Hydro-mulch and organic fertilizer composition and process - A combination of mulch and sterilized organic fertilizer is provided for hydro seeding and hydro-mulching for seed establishment and erosion control. The composition includes hammer milled straw, horse manure and urine, sterilized with heat and processed to provide an optimal particle size. The incorporation of horse manure utilizes a dispersible natural fertilizer collected and processed within a certain time frame which provides an efficient method of recycling “green” horse manure” and liquid waste having a higher acidity than decomposed animal waste. Tackifiers and flocculants such as ground paper aid pumpability and help tack the straw fibers to the ground. The equipment includes a gas heat source, a dryer vessel and a processing unit. The dryer vessel receives the bedding composed of straw and manure for contact with the heated gases to convert the same to a sterilized dry material. | 2016-01-07 |
20160002121 | METHODS AND COMPOSITIONS FOR RADIOHALOGEN PROTEIN LABELING - Methods and compositions are provided for labeling proteins with radiohalogen-label reagents. Radiohalogen-labeled proteins may be used for imaging studies, as therapeutics and in diagnostic tests. The [ | 2016-01-07 |
20160002122 | Process to Make Olefins from Isobutanol - A process for the conversion of an alcohol mixture to make propylene may include introducing into a reactor a stream that includes the alcohol mixture. The alcohol mixture may include 20 to 100 weight percent isobutanol. The process may include contacting the stream with a single catalyst at a temperature above 450° C. in the reactor at conditions effective to dehydrate the isobutanol, forming C | 2016-01-07 |
20160002123 | PROCESS FOR THE SELECTIVE DIMERISATION OF ETHYLENE TO 1-BUTENE - The invention concerns a process for the selective dimerization of ethylene to 1-butene employing a catalytic composition comprising at least one alkoxy or aryloxy titanium compound, at least one additive selected from ether type compounds and at least one aluminium compound. | 2016-01-07 |
20160002124 | CATALYTIC COMPOSITION AND PROCESS FOR THE SELECTIVE DIMERIZATION OF ETHYLENE TO 1-BUTENE - The invention describes a catalytic composition obtained by interaction of an alkyl titanate on the one hand with a preformed mixture of an alkylaluminium and a Lewis base on the other hand. The invention also describes the use of said composition in a process for the selective dimerization of ethylene to 1-butene. | 2016-01-07 |
20160002125 | NOZZLE DESIGN FOR IONIC LIQUID CATALYZED ALKYLATION - Systems for ionic liquid catalyzed hydrocarbon conversion comprise a reactor vessel, a mixing device in fluid communication with the reactor vessel, and at least one circulation loop in fluid communication with the reactor vessel and the mixing device. The mixing device may comprise an upper venturi, at least one feed injection component, and a lower venturi. Such systems may be used for ionic liquid catalyzed alkylation reactions. Processes for ionic liquid catalyzed hydrocarbon conversion are also disclosed. | 2016-01-07 |
20160002126 | Oxidative Dehydrogenation Process With Hydrocarbon Moderator Gas and Reduced Nitrogen Feed - Oxidative dehydrogenation includes: (a) providing a gaseous feed stream to a catalytic reactor, the feed stream comprising a dehydrogenation reactant, oxygen, superheated steam, hydrocarbon moderator gas and optionally nitrogen, wherein the molar ratio of moderator gas to oxygen in feed stream is typically from 4:1 to 1:1 and the molar ratio of oxygen to nitrogen in the feed stream is at least 2; (b) oxidatively dehydrogenating the reactant in the reactor to provide a dehydrogenated product enriched effluent product stream; and (c) recovering dehydrogenated product from the effluent product stream. One preferred embodiment is a process for making butadiene including dimerizing ethylene to n-butene in a homogeneous reaction medium to provide a hydrocarbonaceous n-butene rich feed stream and oxidatively dehydrogenating the n-butene so formed. | 2016-01-07 |
20160002127 | PROCESS FOR THE PRODUCTION OF CHLORINATED PROPANES - Processes for the production of chlorinated propanes are provided. The processes comprise catalyzing the chlorination of 1,1,1,3-tetrachloropropane with aluminum chloride, either alone or in combination with ferric chloride. Low intensity conditions are appropriate for the process, e.g., temperatures of from ambient to 100° C. and pressures of from ambient to 200 psig may be used. Even though low intensity conditions are used, the aluminum chloride provides at least 1.5 times greater the conversion rate and/or productivity of 1,1,1,3-tetrachloropropane as compared to ferric chloride when used as a single catalyst under similar processing conditions. | 2016-01-07 |
20160002128 | HIGH PURITY E-1-CHLORO-3,3,3-TRIFLUOROPROPENE AND METHODS OF MAKING THE SAME - The present invention discloses high purity E-1-chloro-3,3,3-trifluoropropene (1233zd(E)) and methods to produce the same. More specifically, the present invention discloses the methods of making 1233zd(E) essentially free of toxic impurities (e.g. 2-chloro-3,3,3-trifluoropropene (1233xf), chlorotetrafluoro-propene (1224), and 3,3,3-trifluoropropyne). The present invention further provides methods for making high purity 1233zd(E) with concentration of 1233xf and 1224 at or below 200 parts per million (ppm) and 3,3,3-trifluoropropyne impurities at or below 20 ppm. Formation of 1233xf impurity can be avoided if pure 1,1,1,3,3-pentachloropropane is used as a starting material. It was also found that formation of 1233xf is avoided if a liquid phase manufacturing process is used. | 2016-01-07 |
20160002129 | PROCESS FOR HYDROGENOLYSIS OF GLYCEROL - A process for the hydrogenolysis of glycerol to produce propylene glycol as the major product comprising contacting the glycerol with hydrogen in the presence of a heterogeneous catalyst under conditions for the formation of propylene glycol is disclosed. In particular, propylene glycol is formed with a selectivity of greater than about 90%. | 2016-01-07 |
20160002130 | Divalent Ion Removal From Monoethylene Glycol (MEG) Feed Streams - A system and process for removing divalent ions from a MEG feed stream is presented. The system includes a chemical treatment tank where chemicals are mixed with the feed stream to form insoluble carbonate and hydroxide salts. The system also includes a membrane-type solid-liquid separation unit that receives the feed stream from the chemical treatment tank and separates it into a filtrate containing MEG and a retentate containing the insoluble salts. The system may also include washing the retentate to remove additional MEG, which is then recycled to a MEG regeneration or reclamation process. The system may also include a dryer that receives waste slurry from the solid-liquid separation unit and dries it to form a solid waste, thereby facilitating its handling, storage, and disposal. | 2016-01-07 |
20160002131 | VAPOR RECOMPRESSION - Provided are processes for recovering thermal energy and utilizing the recovered thermal energy as a heat source. The processes comprise distilling a butanol and water composition in a distillation unit, whereby the distillation produces a vapor comprising butanol and water at a pressure P | 2016-01-07 |
20160002132 | METHOD FOR PRODUCING BUTANOL USING EXTRACTIVE FERMENTATION - Provided herein are methods for recovering butanol from a fermentation medium. The methods comprise providing a fermentation medium comprising butanol, water, and a recombinant microorganism comprising a butanol biosynthetic pathway, wherein the recombinant microorganism produces butanol; contacting the fermentation medium with a water immiscible organic extractant composition comprising a dry solvent to form a butanol-containing organic phase and an aqueous phase; and recovering the butanol from the butanol-containing organic phase. | 2016-01-07 |
20160002133 | NOVEL PROCESS FOR GENERATING HEMP OIL WITH A HIGH CANNABIDIOL (CBD) CONTENT - A method for producing hemp oil, comprising decarboxylation of CBDA in hemp oil; short-path evaporation of CBD from the decarboxylated hemp oil to produce CBD oil; selective THC to CBN conversion performed on the decarboxylated hemp oil. | 2016-01-07 |
20160002134 | PROCESS FOR PREPARING DIARYL OXIDES BY DECARBOXYLATION - Provided is a process for the preparation of diaryl oxide compounds. The process uses a mixed metal oxide catalyst containing oxides of aluminum and magnesium to decarboxylate a diaryl carbonate compound to yield the diaryl oxide compound. | 2016-01-07 |
20160002135 | Fluoronation of alpha-Haloalkyl Ketones - The present invention provides methods and processes for producing α-fluoroalkyl ketones from non-fluoro α-haloalkyl ketones using a fluorohydrogenate compound. In some embodiments, the fluorohydrogenate compound is an ionic liquid. One particular method of the invention utilizes a fluorohydrogenate ionic liquid compound of the formula: | 2016-01-07 |
20160002136 | OPTIMIZED SEPARATION TECHNIQUE FOR WORK-UP OF HOMOGENEOUSLY CATALYSED HYDROFORMYLATION MIXTURES - The invention relates to a method for producing alcohols by homogeneously catalysed hydroformylation of olefins to aldehydes and subsequent hydration of the aldehydes. The invention further relates to a system for carrying out the method. The main focus is on the separation technique for work-up of the hydroformylation mixture. The problem addressed by the invention is that specifying a work-up method for hydroformylation mixtures that utilises the specific advantages of known separation technologies but at the same time largely avoids the specific disadvantages of said separation technologies. The most important objective is to create a catalyst separation system that is as complete and at the same time conservative as possible and that operates in a technically reliable manner and entails low investment and operating costs. The method should be unrestrictedly suitable for processing the reaction output from oxo systems in “world scale” format. The problem is solved by combining membrane separation units and a thermal separation unit, the thermal separation unit being operated in such a manner that 80% to 98% of the mass introduced with the product stream into the thermal separation unit exits the thermal separation unit again as a head product. | 2016-01-07 |
20160002137 | PROCESS FOR REMOVING FORMALDEHYDE FROM A COMPOSITION COMPRISING GLYCOLALDEHYDE - A process for reducing the percentage by weight of formaldehyde present in a composition comprising glycolaldehyde, wherein formaldehyde is transformed into one or more formaldehyde acetal(s) and removed from the reactive distillation reaction solution by reactive distillation in the presence of at least one alcohol and a catalyst. | 2016-01-07 |
20160002138 | METHODS FOR SELECTIVE OXIDATION OF ALPHA TOCOTRIENOL IN THE PRESENCE OF NON-ALPHA TOCOTRIENOLS - A method of producing alpha-tocotrienol quinone or a stereoisomer thereof, the method comprising selective opening of alpha-tocotrienol chroman to alpha-tocotrienol quinone in the presence of non-alpha tocotrienol chromans by oxidizing alpha-to-cotrienol with a metal salt oxidizing agent, wherein the stoichiometric ratio of metal salt oxidizing agent/alpha-tocotrienol is at least 4:1 and wherein said metal oxidizing agent is added in sequential additions, in order to reduce oxidation of any amounts of non-alpha tocotrienol chromans that might have been present in the starting alpha-tocotrienol chroman material. This process uses conditions favoring oxidation rates of the alpha tocotrienol chroman vs. the non-alpha tocotrienol chromans. | 2016-01-07 |
20160002139 | OXIDATION OF ALKANES TO ALCOHOLS - The invention provides processes and materials for the efficient and cost-effective functionalization of alkanes, such as methane from natural gas, to provide esters, alcohols, and other compounds. The method can be used to produce liquid fuels such as methanol from a natural gas methane-containing feedstock. The soft oxidizing electrophile, a compound of a main group, post-transitional element such as Tl, Pb, Bi, and I, that reacts to activate the alkane C—H bond can be regenerated using inexpensive regenerants such as hydrogen peroxide, oxygen, halogens, nitric acid, etc. Main group compounds useful for carrying out this reaction includes haloacetate salts of metals having a pair of available oxidation states, such as Tl, Pb, Bi, and I. The inventors herein believe that a unifying feature of many of the MXn electrophiles useful in carrying out this reaction, such as Tl, Pb, and Bi species, is their isoelectronic configuration in the alkane-reactive oxidation state; the electrons having the configuration [Xe]4f145d10, with an empty 6s orbital. However, the iodine reagents have a different electronic configuration. | 2016-01-07 |
20160002140 | SELECTIVE SYNTHESIS OF 2-OCTYL ACRYLATE BY ACID CATALYZED ESTERIFICATION OF 2-OCTANOL AND ACRYLIC ACID - A method of making 2-octyl acrylate comprising reacting 2-octanol with acrylic acid in the presence of an acid catalyst and added water is described. The 2-octanol may be derived from renewable resources, such as castor oil. The method is efficient and provides selectivity for 2-octyl acrylate. | 2016-01-07 |
20160002141 | SYNTHESIS OF CALEBIN-A AND ITS BIOLOGICALLY ACTIVE ANALOGS - Disclosed is a simple, economical, industrially scalable green synthetic process for Calebin-A and its biologically active analogs. | 2016-01-07 |
20160002142 | PHENYLGLYOXYLIC ACID DERIVATIVES AND THEIR PREPARATION AND USE - The invention provides novel phenylglyoxylic acid derivatives, which may be useful as intermediates for preparing stereoisomerically enriched drug compounds. The invention also provides methods of making phenylglyoxylic acid derivatives, and uses of phenylglyoxylic acid derivatives. | 2016-01-07 |
20160002143 | METHOD FOR PRODUCING DIARYL CARBONATE - The present application relates to a method for the continuous production of diaryl carbonate from phosgene and of at least one monohydroxy compound (monophenol) in the presence of catalysts, and to the use thereof for the production of polycarbonates. | 2016-01-07 |
20160002144 | HIGH REFRACTIVE INDEX POLYMER COMPOSITION FOR OPTHALMIC APPLICATIONS - A monomer for a polymerisable composition is described, the monomer having the formula (I): | 2016-01-07 |
20160002145 | SYNTHESIS OF ACYCLIC AND CYCLIC AMINES USING IRON-CATALYZED NITRENE GROUP TRANSFER - The present invention provides novel synthetic methods for making acyclic secondary amines by reacting an azide with a compound bearing one or more C—H groups, catalyzed by a Fe | 2016-01-07 |
20160002146 | METHOD FOR PRODUCING HALOGEN-N,N-DIMETHYLBENZYLAMINES - The invention relates to a method for producing halogen-N,N-dimethylbenzylamines wherein halogen=chlorine or bromine, preferably chloro-N,N-dimethylbenzylamines, preferably ortho-chloro-N,N-dimethylbenzylamine (o-Cl-DMBA), by reductive amination in the absence of sulfur. | 2016-01-07 |
20160002147 | METHOD OF SYNTHESISING AMINO ACID BY METATHESIS, HYDROLYSIS, THEN HYDROGENATION - A method of synthesising an amino acid from an unsaturated fatty compound I that includes at least the following steps: cross-metathesis with a short unsaturated compound II, one of compounds I or II comprising a nitrile function and the other of these compounds II or I an ester function, so as to obtain and recover at least one monounsaturated nitrile ester NEU; hydrolysis of the NEU in unsaturated acid nitrile NAU; hydrogenation of the NAU to saturated amino acid AA; and then purification of the AA, if applicable, in particular by crystallisation. Also, a polymer obtained by polymerisation using the amino acid synthesised according to the method. | 2016-01-07 |
20160002148 | NEPRILYSIN INHIBITORS - In one aspect, the invention relates to compounds having the formula XII: | 2016-01-07 |
20160002149 | NOVEL CARBOXAMIDE COMPOUNDS - Compounds of the formula (I), in which the substituents are as defined in claim | 2016-01-07 |
20160002150 | KETENE IMINE COMPOUND, POLYESTER FILM, BACK SHEET FOR SOLAR CELL MODULE, AND SOLAR CELL MODULE - A polyester resin composition including a ketene imine compound represented by the Formula (1) and polyester shows excellent hydrolysis resistance and prevents yellowing. At least one of R | 2016-01-07 |
20160002151 | METATHESIS PROCESS COMPRISING THE EXTRACTION OF THE ETHYLENE FORMED BY MEANS OF A MEMBRANE - A process for the metathesis of two α-olefin compounds, wherein it comprises the use of at least one membrane for extracting ethylene from the reaction medium, said membrane being permeable to gases and impermeable to liquids. A process for the metathesis of two α-olefin compounds, carried out in a reaction device including two zones separated by said at least one membrane: a first zone, fed with reactants and catalyst, in which the liquid-phase metathesis reaction is initiated and the liquid reaction medium is circulated in contact with the wall constituted by the membrane, and a second zone, fed with a gaseous stream that is inert with respect to the membrane and the constituents of the reaction medium of the first zone. | 2016-01-07 |
20160002152 | UREA DERIVATIVES AND THEIR USE AS FATTY-ACID BINDING PROTEIN (FABP) INHIBITORS - The invention provides novel compounds having the general formula (I) | 2016-01-07 |
20160002153 | FLUORINE-CONTAINING NITRILE-OXIDE COMPOUND - A stable and easily producible compound of the formula (I): | 2016-01-07 |
20160002154 | UV-ABSORBING COMPOUNDS WITH AT LEAST ONE REACTIVE HYDROGEN - UV-absorbing compounds are provided that have at least one reactive hydrogen. These compounds have structures: wherein the generic notations have meanings as described herein. Also provided are formulations comprising a UV-absorbing compounds. | 2016-01-07 |
20160002155 | SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B - Inhibitors of HBV replication of Formula (I) | 2016-01-07 |
20160002156 | N-HYDROXYLSULFONAMIDE DERIVATIVES AS NEW PHYSIOLOGICALLY USEFUL NITROXYL DONORS - The invention relates to N-hydroxysulfonamide derivatives that donate nitroxyl (HNO) under physiological conditions and are useful in treating and/or preventing the onset and/or development of diseases or conditions that are responsive to nitroxyl therapy, including heart failure and ischemia/reperfusion injury. Novel N-hydroxysulfonamide derivatives release NHO at a controlled rate under physiological conditions, and the rate of HNO release is modulated by varying the nature and location of functional groups on the N-hydroxysulfonamide derivatives. | 2016-01-07 |
20160002157 | NOVEL HIGH PENETRATION DRUGS AND THEIR COMPOSITIONS THEREOF FOR TREATMENT OF PARKINSON DISEASES - One aspect of the invention provides a composition of novel high penetration compositions (HPC) or a high penetration prodrug (HPP) for treatment of Parkinson's disease. The HPCs/HPPs are capable of being converted to parent active drugs or drug metabolites after crossing the biological barrier and thus can render treatments for the conditions that the parent drugs or metabolites can. Additionally, the HPPs are capable of reaching areas that parent drugs may not be able to access or to render a sufficient concentration at the target areas and therefore render novel treatments. The HPCs/HPPs can be administered to a subject through various administration routes, e.g., locally delivered to an action site of a condition with a high concentration or systematically administered to a biological subject and enter the general circulation with a faster rate. | 2016-01-07 |
20160002158 | ASYMMETRIC SYNTHESIS OF A SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDE - The present invention provides an improved method for the large scale production of the compound 4-{[(2R,3S,4R,5S)-3-(3-chloro-2-fluoro-phenyl)-4-(4-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic acid. | 2016-01-07 |
20160002159 | PERFLUORO-TERT-BUTYL HYDROXYPROLINE - The present invention provides novel analogues of alpha amino acids, comprising a perfluoro-tert-butyl group, and molecules comprising the novel analogues. Also provided are a wide range of applications of the novel analogues in therapeutics, theranostics and pharmaceuticals as well as in imaging applications. In particular, the use of the novel analogues in detecting or modifying a target molecule is provided. | 2016-01-07 |
20160002160 | CRYSTALLINE (3Z,5S)-5-(HYDROXYMETHYL)-1-[(2'-METHYL-1,1'-BIPHENYL-4-YL)CARBONYL]PYRRO- LIDIN-3-ONE O-METHYLOXIME, AND METHODS OF USING THE SAME - Crystalline (3Z,5S)- | 2016-01-07 |
20160002161 | PLANT GROWTH REGULATING COMPOUNDS - The present invention relates to novel strigolactam derivatives, to processes and intermediates for preparing them, to plant growth regulator compositions comprising them and to methods of using them for controlling the growth of plants and/or promoting the germination of seeds. | 2016-01-07 |
20160002162 | PROCESSES FOR RECOVERING VALUABLE COMPONENTS FROM A CATALYTIC FAST PYROLYSIS PROCESS - Methods of separating products from the catalytic fast pyrolysis of biomass are described. In a preferred method, a portion of the products from a pyrolysis reactor are recovered and separated using a quench system and solvent contacting system that employs materials produced in the pyrolysis process. | 2016-01-07 |
20160002163 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF - Described herein are antimicrobial compounds identified via a high-throughput screen to identify compounds that produce anucleate cells in | 2016-01-07 |
20160002164 | COMPOUND WITH BRANCHING ALKYL CHAINS, METHOD FOR PREPARING THE SAME, AND USE THEREOF IN PHOTOELECTRIC DEVICE - The invention discloses a compound having branching alkyl chains, the method for preparing the same and use thereof in photoelectric devices. By applying the branching alkyl chains as the solubilizing group to the preparation of organic conjugated molecules (for example, organic conjugated polymers), the number of methylenes between the resultant alky side chains and the backbone, i.e., m>1, which can effectively reduce the effect of the alkyl chains on the backbone π-π stacking, thereby ensuring the solubility of the organic conjugated molecule while greatly increasing the mobility of their carriers. It is suitable for an organic semiconductor material in photoelectric devices such as organic solar cells, organic light emitting diodes and organic field effect transistors, etc. | 2016-01-07 |
20160002165 | SALT OF PYRROLIDIN-3-YL ACETIC ACID DERIVATIVE AND CRYSTALS THEREOF - An organic carboxylic acid salt of 2-[(3S,4R)-1-{[2-chloro-6-(trifluoromethyl)phenyl]methyl}-3-{[1-(cyclohex-1-en-1-ylmethyl) piperidin-4-yl]carbamoyl}-4-methylpyrrolidin-3-yl]acetic acid and a crystal thereof. | 2016-01-07 |
20160002166 | Process for Preparing Atazanavir Sulphate - The present invention relates to a process for the preparation of Compound (A): | 2016-01-07 |
20160002167 | BIVALENT LINKERS AND CONJUGATES THEREOF - Bivalent linkers to be included in or for preparing vitamin, drug, diagnostic agent, and/or imaging agent conjugates are described. | 2016-01-07 |
20160002168 | USE OF QUINOLINE DERIVATIVES FOR IMPROVING PLANT YIELD - Compounds (A) can be used for increasing the yield of useful plants or crop plants with respect to their harvested plant organs, wherein the Compound (A) is selected from compounds of the formula (I) and hydrates or salts thereof, | 2016-01-07 |
20160002169 | HETEROCYCLIC COMPOUND - The present invention provides a heterocyclic compound having a RORγt inhibitory action. | 2016-01-07 |
20160002170 | CRYSTALLINE FORMS OF -ACETIC ACID - The present disclosure relates to crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid (Compound A), the process of preparing crystalline forms of Compound A, the pharmaceutical compositions containing them, and the methods of use thereof. | 2016-01-07 |
20160002171 | PRODRUGS OF MULTIFUNCTIONAL NITROXIDE DERIVATIVES AND USES THEREOF - Prodrugs of compounds comprise a nitric oxide donor and a reactive oxygen species (ROS) degradation catalyst, in particular, 1-pyrrolidinyloxy, 1-piperidinyloxy, and 1-azepanyloxy derivatives, and pharmaceutical compositions thereof. These compounds and pharmaceutical compositions are useful in prevention, treatment or management of diseases, disorders or conditions associated with oxidative stress or endothelial dysfunction. | 2016-01-07 |
20160002172 | PHENYLPYRAZOLE DERIVATIVES AS POTENT ROCK1 AND ROCK2 INHIBITORS - The present invention provides compounds of Formula (I): (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same. | 2016-01-07 |
20160002173 | NANOPARTICULATE AND MACROPARTICULATE FORMULATIONS - The present invention is directed to particles prepared via the polymerization of at least one surfactant and an isocyanate-containing compound. Pharmaceutical compositions prepared using these particles are also described. | 2016-01-07 |
20160002174 | CXCR4 Antagonists for the Treatment of Medical Disorders - The invention provides compounds, pharmaceutical compositions and methods of use of certain compounds that are antagonists of the chemokine CXCR4 receptor for the treatment of proliferative conditions mediated by CXCR4 receptors. The compounds provided interfere with the binding of SDF1 to the receptor. These compounds are particularly useful for treating or reducing the severity of hyperproliferative diseases by inhibiting metastasis. | 2016-01-07 |
20160002175 | Pyrimidine-2,4-Diamine Derivatives for Treatment of Cancer - A compound of formula (I), or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer or other diseases that may benefit from inhibition of MTH1. | 2016-01-07 |
20160002176 | ERK INHIBITORS AND USES THEREOF - Compounds, compositions thereof, and methods for inhibiting one or both ERK1 and ERK2 kinases are provided. | 2016-01-07 |
20160002177 | COMT INHIBITORS - The present invention relates to compounds of formula | 2016-01-07 |
20160002178 | POLYAMINE-FATTY ACID DERIVED LIPIDOIDS AND USES THEREOF - The present disclosure provides polyamine-fatty acid derived lipidoids (e.g., compounds of Formula (I) or (II)) and methods of preparing the lipidoids. A described lipidoid includes R—C(═O)—O— moieties (where R is a lipid moiety), which may be hydrolyzed into non-toxic fatty acids. Also provided are compositions including a described lipidoid and an agent (e.g., polynucleotide, small molecule, peptide, or protein). The present disclosure also provides methods, kits, and uses that involve the lipidoids or compositions for delivering an agent to a subject, tissue, or cell and/or for treating and/or preventing a range of diseases, such as genetic diseases, proliferative diseases, hematological diseases, neurological diseases, immunological diseases, gastrointestinal diseases, respiratory diseases, painful conditions, psychiatric disorders, and metabolic disorders. | 2016-01-07 |
20160002179 | SUBSTITUTED IMIDAZOLE AND (1,2,4)TRIAZOLE COMPOUNDS AS FUNGICIDES - The present invention relates to compounds of the formula I | 2016-01-07 |
20160002180 | ANTIVIRAL COMPOUNDS - The present invention discloses compounds of Formula (I) wherein the variables in Formula (I) are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula (I) in the prevention or treatment of HCV infection. | 2016-01-07 |
20160002181 | METHOD FOR PRODUCING A POLYMERIZABLE UV ABSORBER - The present invention relates to a two-stage preparation process for an organic UV absorber that has a (meth)acrylate group in the molecule and which as a result is particularly suitable for curable UV protective coatings. One example of the preparation process is: | 2016-01-07 |
20160002182 | CRYSTALLINE FORMS OF TRYOSINE KINASE INHIBITORS AND THEIR SALTS - The invention relates to various polymorphic forms and amorphous form of sodium 4-((3-(4-cyclohexylpiperazin-1-yl)-6-oxo-6H-anthra[1,9-cd]isoxazol-5-yl)amino)benzate, including the polymorphic form A, mixtures of the polymorphs, process for the preparation thereof and the use thereof in a pharmaceutical composition containing thereof. | 2016-01-07 |
20160002183 | SYNTHESIS OF TETRACYCLINES AND INTERMEDIATES THERETO - The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides more efficient routes for preparing the enone intermediate and allows for substituents at positions 4a, 5, 5a, and 12a of the tetracycline ring system. | 2016-01-07 |
20160002184 | NEW BACTERIAL QUORUM SENSING REGULATOR AND MEDICAL USE THEREOF - The invention relates to a compound of formula I, and a preparation method and use thereof. The compound has a bacterial quorum-sensing regulatory effect, and can be used for prevention and/or treatment of a disease caused by a bacterial infection. | 2016-01-07 |
20160002185 | CIS-MORPHOLINONE AND OTHER COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER - The present invention provides MDM2 inhibitor compounds of Formula (I), or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor. | 2016-01-07 |
20160002186 | METHODS AND INTERMEDIATES FOR PREPARING PHARMACEUTICAL AGENTS - The invention provides methods and intermediates that are useful for preparing a compound of formula I: | 2016-01-07 |
20160002187 | APOPTOSIS-INDUCING AGENT FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES - Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. | 2016-01-07 |
20160002188 | NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN - The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below: | 2016-01-07 |
20160002189 | PROCESS FOR THE PREPARATION OF SUBSTITUTED OXIRANES AND TRIAZOLES - The present invention relates to a process for the preparation of the compounds II | 2016-01-07 |
20160002190 | SOLID FORMS OF 5-(HALOMETHYL)FURFURAL AND METHODS FOR PREPARING THEREOF - Provided are solid forms of 5-(halomethyl)furfural, including a crystalline form of 5-(chloromethyl)furfural. Provided are also methods for preparing solid forms of 5-(halomethyl)furfural by crystallization using certain solvents. | 2016-01-07 |
20160002191 | METHODS FOR PURIFYING 5-(HALOMETHYL)FURFURAL - The present disclosure provides methods for purifying a 5-(halomethyl)furfural composition, including 5-(chloromethyl)furfural, at operating conditions that decrease or minimize the decomposition or degradation of 5-(chloromethyl)furfural during the process. The methods may employ certain solvents, operating conditions, and/or techniques (e.g., gas stripping). The gaseous 5-(halomethyl)furfural produced from the process can be condensed or deposited to yield 5-(halomethyl)furfural in liquid or solid form. The solid 5-(halomethyl) furfural may be amorphous or crystalline. | 2016-01-07 |
20160002192 | 2-(ALKOXY OR ARYLOXY CARBONYL)-4-METHYL-6-(2,6,6-TRIMETHYLCYCLOHEX-1- ENYL)HEX-2-ENOIC ACID COMPOUNDS, ITS PREPARATION AND USE - Compounds of the formula 1 | 2016-01-07 |
20160002193 | ANTICANCER COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF - The invention disclosed herein relates to novel Peribysin E analogues of general formula-I. Further the invention provides simple, economical and short synthesis of Peribysin E and its analogues of Formula I, in good yield and purity leading to the identification of more potent cell adhesion inhibitors. | 2016-01-07 |
20160002194 | 1 -(DIMETHYLAMINO)ETHYL-SUBSTITUTED 6H-BENZO[C]CHROMEN-6-ONES AGAINST SENILE DEMENTIA - This invention relates to novel (±)1-(Dimethylamino)ethyl substituted 6H-benzo[c]chromen-6-one compounds which are useful as pharmaceutical compositions. | 2016-01-07 |
20160002195 | CANNABINERGIC NITRATE ESTERS AND RELATED ANALOGS - The present technology relates to novel cannabinergic nitrate esters and related analogs, process of preparation, pharmaceutical compositions and their methods of use as medicaments, pharmacological tools and/or biomarkers. The novel cannabinergic nitrate ester compounds provide medicaments useful in treating a variety of diseases and medical disorders. | 2016-01-07 |
20160002196 | METHOD FOR PRODUCING GLYCOLIDE - A method for producing glycolide (GL) by heating a glycolic acid oligomer (GAO) to depolymerize the GAO. The method for producing GL comprises: a step 1 of heating a mixture containing a GAO having a terminal COOH concentration of 400 eq/t or less and a polar organic solvent to a GAO depolymerization temperature under ambient pressure or reduced pressure; a step 2 of continuing the heating at the temperature for depolymerizing of the GAO and then codistilling out the produced GL and the solvent from the depolymerization reaction system to the outside the reaction system; and a step 3 of obtaining GL from the codistillation product. In the method for producing GL, the GAO is preferably prepared by a GAO production method which comprises a step of condensing glycolic acid (GA) and a dehydration step of continuing the heating together with a polar organic solvent or a depolymerization reaction solution to allow the GA condensation reaction to continue. | 2016-01-07 |
20160002197 | METHOD FOR PRODUCING GLYCOLIDE - A method for producing a GL comprising: (I) a heating step of heating a mixture either under normal pressure or reduced pressure at a temperature at which a polyglycolic acid (PGA) undergoes depolymerization, the mixture containing the PGA and a polyethylene glycol ether which is represented by the formula: X—O—(—CH | 2016-01-07 |
20160002198 | AMIDE DERIVATIVES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS INSECTICIDE - An object of the present invention is to provide a compound represented by Formula (1): | 2016-01-07 |
20160002199 | ACID GENERATORS AND PHOTORESISTS COMPRISING SAME - Acid generator compounds are provided that are particularly useful as photoresist composition components. Preferred acid generators include cyclic sulfonium compounds that comprise a covalently linked acid-labile group. | 2016-01-07 |
20160002200 | COMPOSITIONS, APPARATUS, SYSTEMS, AND METHODS FOR RESOLVING ELECTRONIC EXCITED STATES - The present disclosure relates, according to some embodiments, to molecules, including conjugated fused polycyclic molecules, that may receive excited state energy from other molecules (e.g., light-absorbing molecules) or directly from the irradiation sources. According to some embodiments, the disclosure relates to molecules, including conjugated fused polycyclic molecules, that may resolve (e.g., quench, dissipate) excited state energy, normally by way of releasing it as heat. (e.g., as heat). Conjugated fused polycyclic molecules of various structures are disclosed including Formula III: | 2016-01-07 |
20160002201 | HISTONE DEMETHYLASE INHIBITORS - Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like. | 2016-01-07 |
20160002202 | 2',6'-DIOXO-3'-DEUTERO-PIPERDIN-3-YL-ISOINDOLINE COMPOUNDS - The present application describes 2-(2′,6′-dioxo-3′-deutero-piperidin-3′-yl)isoindoles, deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treating using the same. | 2016-01-07 |
20160002203 | QUINAZOLIN-4(3H)-ONE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF - The present disclosure relates to Quinazolin-4(3H)-one-Type Piperidine Compounds, such as those of Formula (I) and the pharmaceutically acceptable salts and solvates thereof, wherein R | 2016-01-07 |
20160002204 | GLS1 INHIBITORS FOR TREATING DISEASE - Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I: | 2016-01-07 |
20160002205 | SUBSTITUTED 2-AMINOPYRIDINE PROTEIN KINASE INHIBITOR - Disclosed are a | 2016-01-07 |
20160002206 | INHIBITORS OF BRUTON'S TYROSINE KINASE - This application discloses compounds according to generic Formula I: (I) wherein all variables are defined as described herein, which inhibit BTK. The compounds disclosed herein are useful to modulate the activity of BTK and treat diseases associated with excessive BTK activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions containing compounds of Formula I and at least one carrier, diluent or excipient. | 2016-01-07 |
20160002207 | NEW DIHYDROQUINOLINE-2-ONE DERIVATIVES - The invention provides novel compounds having the general formula (I) | 2016-01-07 |